1. Multistage malaria shot shows mid-term protection in Malian adults – but transmission benefits still unproven In this randomized, double blind trial from peri urban Mali, 34 healthy adults (18–50 years) with...
The trajectory of vaccine development in high‑income countries is approaching a turning point. With the licensure of respiratory syncytial virus (RSV) vaccines and monoclonal antibodies, most high‑incidence, high‑burden...